NYSE:IMPR Imprivata (IMPR) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free IMPR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$19.26▼$19.2650-Day Range N/A52-Week Range$9.00▼$20.32VolumeN/AAverage Volume258,396 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Imprivata alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Imprivata Stock (NYSE:IMPR)Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report IMPR Stock News HeadlinesApril 24, 2024 | finance.yahoo.comSecure Messaging in Healthcare Market Size Worth US$ 3,501.6 Million by 2034 at CAGR of 17.4%: Fact.MR ReportApril 22, 2024 | finance.yahoo.comAdvanced Biometrics Industry Analysis Report 2024: Evolution Timeline, Emerging Trends, Patents Landscape, Sector Impacts, Real-world InnovationsApril 24, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 9, 2024 | finanznachrichten.deClinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarketsApril 9, 2024 | finance.yahoo.comClinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™March 19, 2024 | markets.businessinsider.comUnauthorized Access to Employee Mobile Devices Leads to More Than Half of Organizations Experiencing a Data Breach, New Report FindsMarch 14, 2024 | seekingalpha.comAware, Inc. (AWRE) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | msn.comStepping Hill Hospital partners with CDW to improve IT systemsApril 24, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.February 27, 2024 | finance.yahoo.comImprivata launches new Biometric Patient Identity solution to protect patient privacy and address misidentification crisisFebruary 9, 2024 | benzinga.comHIGHLAND CAPITAL PARTNERS VI LP's Net WorthFebruary 6, 2024 | finance.yahoo.comCyber Threat Mitigation: Semperis Chief Financial Officer Jeff Bray, Live from NYSEJanuary 9, 2024 | finance.yahoo.comAkrete names Nicole Stenclik as its first president, spearheading new agency leadership structureDecember 27, 2023 | msn.comWhy Is Zscaler (ZS) Up 15.9% Since Last Earnings Report?December 26, 2023 | msn.comWhat’s new and what’s working, in B2B channel partner marketingDecember 19, 2023 | msn.comWhy These 7 Cloud Computing Stocks Should be on Your Radar in 2024December 11, 2023 | finance.yahoo.comImprivata Announces Strategic Leadership Transition and Welcomes Fran Rosch as New CEONovember 28, 2023 | finanznachrichten.deZscaler, Inc.: Zscaler Reports First Quarter Fiscal 2024 Financial ResultsNovember 27, 2023 | markets.businessinsider.comZscaler Reports First Quarter Fiscal 2024 Financial ResultsNovember 8, 2023 | msn.comPhilipstown and Putnam Election ResultsNovember 3, 2023 | forbes.comMobile Devices: Helping Reduce Staff Burnout And Improve Patient CareOctober 27, 2023 | msn.comElection GuideOctober 9, 2023 | msn.comCybersecurity Stock Pops As It Pulls Off This Rare TrifectaSeptember 28, 2023 | finance.yahoo.comOrdr Continues Strong Commitment to Healthcare Industry with Appointment of Wes Wright as Chief Healthcare OfficerSeptember 25, 2023 | benzinga.comHealthcare Cybersecurity Market Size, Share with Focus on Emerging Technologies, Top Countries Data, Top Key Players Update, and Forecast 2028September 22, 2023 | uk.news.yahoo.comCrowdStrike (CRWD) Ups Outlook for Key Margins on Strong DemandSeptember 20, 2023 | finance.yahoo.comZscaler (ZS) Announces New Zero-Trust Security SolutionSee More Headlines Receive IMPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/16/2016Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMPR CUSIPN/A CIK1328015 Webwww.imprivata.com Phone+1-781-6742700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report IMPR Stock Analysis - Frequently Asked Questions How were Imprivata's earnings last quarter? Imprivata, Inc. (NYSE:IMPR) announced its quarterly earnings data on Tuesday, February, 16th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The technology company earned $34.20 million during the quarter, compared to analysts' expectations of $33.15 million. Imprivata's revenue for the quarter was up 17.9% on a year-over-year basis. During the same period last year, the company posted ($0.04) EPS. What other stocks do shareholders of Imprivata own? Based on aggregate information from My MarketBeat watchlists, some companies that other Imprivata investors own include Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA), ASSA ABLOY AB (publ) (ASAZY), Applied DNA Sciences (APDN), Alarm.com (ALRM), 23965 (AF.TO) (AF) and ADT (ADT). This page (NYSE:IMPR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imprivata, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
